COPD phenotypes and co-morbidities: to what extent do they affect a successful response to rehabilitation?

M. Decramer (Leuven, Belgium)

Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Number: 8
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Decramer (Leuven, Belgium). COPD phenotypes and co-morbidities: to what extent do they affect a successful response to rehabilitation?. Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012


Does aging affect the outcome of comprehensive pulmonary rehabilitation in patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 426s
Year: 2003

The psychological status of COPD patients: the impact of the long-term complex treatment and pulmonary rehabilitation
Source: Eur Respir J 2003; 22: Suppl. 45, 53s
Year: 2003

Does disease affect outcome of pulmonary rehabilitation (PR)?
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009


Is the whole body vibration able to improve functional capacity in patients with COPD? A meta-analysis
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015


A disease specific self-management intervention reduces hospital utilization in patients with COPD: a sustained effect at 2 years
Source: Eur Respir J 2003; 22: Suppl. 45, 347s
Year: 2003

The influence of early life events on adult lung function: a mechanism to explain the high rates of chronic respiratory disease seen in populations undergoing a demographic transition
Source: Eur Respir J 2001; 18: Suppl. 33, 506s
Year: 2001

Comorbidity burden and the effect on completion rates and response to pulmonary rehabilitation (PR) in COPD
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015


COPD: Desadaptive illness behavior types patterns
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


COPD patients with low adherence to specific exercise protocols benefit less from rehabilitation
Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation
Year: 2007


How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …?
Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets?
Year: 2019


COPD: Different psychology status (PS) in patients with different cardiac co-morbidities rate
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012

Comparison of comorbidities between two different subgroups in combined assessment of COPD
Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease
Year: 2016

Do patients with COPD who live alone present better functional status than those who do not?
Source: International Congress 2015 – Respiratory physiotherapy assessment and techniques in COPD and asthma
Year: 2015


Do seasonal variations influence the outcome of pulmonary rehabilitation?
Source: Eur Respir J 2004; 24: Suppl. 48, 244s
Year: 2004

Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Source: Eur Respir J 2016; 48: 281-282
Year: 2016


Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Source: Eur Respir J 2016; 48: 279-281
Year: 2016